Beneficial effects of PCSK9 inhibition with alirocumab in familial hypercholesterolemia involve modulation of new immune players
- Marques, P.
- Domingo, E.
- Rubio, A.
- Martinez-Hervás, S.
- Ascaso, J.F.
- Piqueras, L.
- Real, J.T.
- Sanz, M.-J.
Zeitschrift:
Biomedicine and Pharmacotherapy
ISSN: 1950-6007, 0753-3322
Datum der Publikation: 2022
Ausgabe: 145
Art: Artikel
